Viewing StudyNCT02767752



Ignite Creation Date: 2024-05-06 @ 8:33 AM
Last Modification Date: 2024-10-26 @ 12:02 PM
Study NCT ID: NCT02767752
Status: TERMINATED
Last Update Posted: 2018-07-10
First Post: 2016-05-06

Brief Title: Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer
Sponsor: Herlev Hospital
Organization: Herlev Hospital

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
Resectable pancreatic cancer View
Adjuvant View